Anika Therapeutics, Inc. (ANIK)
14.20
-0.10
(-0.70%)
USD |
NASDAQ |
Mar 13, 16:00
14.21
+0.01
(+0.07%)
After-Hours: 20:00
Anika Therapeutics EPS Diluted (Quarterly) : 0.0199 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 1.121 |
| Lantheus Holdings, Inc. | 0.8156 |
| TELA Bio, Inc. | -0.1894 |
| Plus Therapeutics, Inc. | -0.0412 |
| BioStem Technologies, Inc. | 0.0328 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.801M |
| Revenue (Quarterly) | 30.62M |
| Total Expenses (Quarterly) | 28.81M |
| Enterprise Value | 159.06M |
| Gross Profit Margin (Quarterly) | 62.65% |
| Profit Margin (Quarterly) | 5.88% |
| Earnings Yield | -5.34% |
| Normalized Earnings Yield | -5.344 |